Overview

glycoprotein IIb/IIIa


Related Overviews

 

'glycoprotein IIb/IIIa' can also refer to...

glycoprotein IIb/IIIa

Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease

A cold start for oral glycoprotein IIb/IIIa antagonists

Glycoprotein IIb/IIIa receptors and primary stenting in acute myocardial infarction

Glycoprotein IIb/IIIa inhibition and long-term benefit: the stuff of dreams?

Platelet glycoprotein IIb/IIIa receptor inhibitors—end of an era?

Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?

Paradoxical inhibition of fibrinogen binding and potentiation of α-granule release by specific types of inhibitors of glycoprotein IIb–IIIa

Simultaneous integrin αvβ3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty

Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction Dichotomous response as a function of age in the GUSTO V trial

Effect of the Glycoprotein IIb/IIIa Inhibitor Tirofiban on Concentrations of Whole Blood Choline in Acute Coronary Syndromes

153 Left ventricle mural thrombus early after acute myocardial infarction in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors

More evidence for a beneficial effect of platelet glycoprotein IIb/IIIa-blockade during coronary interventions. Latest results from the EPILOG and CAPTURE trials

Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial

Non-ST-elevation acute coronary syndromes management: a fresh look at glycoprotein IIb/IIIa inhibitors

Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable

 

More Like This

Show all results sharing this subject:

  • Chemistry

GO

Show Summary Details

Quick Reference

abbr.: GpIIb/IIIa; a major glycoprotein complex of the platelet surface. GpIIb consists of a heavy chain (containing seven homologous repeats that form a beta propeller and including four Ca2+‐binding sites) ...

Subjects: Chemistry.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.